期刊文献+

天麻素联合氟桂利嗪预防偏头痛发作的临床对照研究 被引量:3

Controlled Clinical Trial of Gastrodine Combined with Flunarizine in Prevention of Migraine Attack
下载PDF
导出
摘要 目的:评价天麻素联合氟桂利嗪预防偏头痛发作的效果及其安全性。方法:半随机对照临床研究。凡符合入选标准的患者按就诊顺序随机分为两组:试验组予以氟桂利嗪5 mg/次,1次/日,睡前服用;天麻素胶囊50 mg/次,3次/日;连续服用30天;对照组:氟桂利嗪5 mg/次,1次/日,睡前服用,连续服用30天。观察治疗前后头痛发作频率、头痛程度、头痛持续时间变化,评价预防效果。结果:两组治疗后头痛发作频率、头痛程度、头痛持续时间均较治疗前改善(P<0.05);试验组受试者治疗后头痛发作频率、头痛持续时间的改善情况优于对照组,两者比较有统计学意义(P<0.05),两组均未发生严重不良反应。结论:天麻素联合氟桂利嗪预防偏头痛发作的效果及安全性良好。 Objective:To evaluate the efficacy and safety of Gastrodine combined with Flunarizine in the prophylaxis of migraine.Methods:Patients consistent with the inclusion criteria were included in the trial.122 patients were enrolled.Patients were randomized by their visiting order into two groups:the experimental group was treated with flunarizine(5 mg once daily)and Gastrodine(50 mg three times daily),and the control group was only treated with 5mg of flunarizine per day.The patients were treated for 1 month con...
出处 《华西医学》 CAS 2008年第5期1031-1032,共2页 West China Medical Journal
关键词 天麻素 氟桂利嗪 偏头痛 半随机对照研究 gastrodine flunarizine migraine controlled clinical trial
  • 相关文献

参考文献6

  • 1偏头痛诊断与防治专家共识组,李焰生.偏头痛诊断与防治专家共识[J].中华内科杂志,2006,45(8):694-696. 被引量:322
  • 2[2]Deeb SM,Biary N,Bahou Y,et al.Flunarizine in Migraine:A Double-blind Placebo-controlled Study(in a Saudi Population)[J].Headache,1992,32(9):461-462.
  • 3[3]Reveiz-Herault L,Cardona AF,Ospina EG,et al.Effectiveness of flunarizine in the prophylaxis of migraine:a meta-analytical review of the literature[J].Rev Neurol,2003,36(10):907-912.
  • 4[5]Silberstein SD,Winner PK,Chmiel JJ.Migraine preventive medication reduces resource utilization[J].Headache,2003,43(3):171.
  • 5[6]Frenken CW,Nuijten ST.Flunarizine,a new preventive approach to migraine[J].A double-blind comparison with placebo.Clin Neurol Neurosurg,1984,86:17-20.
  • 6吕金胜,高全杰,封永勇,向明凤.复方天麻口服液对偏头痛小鼠的作用[J].医药导报,2004,23(3):137-139. 被引量:10

二级参考文献14

  • 1胡深.蛛网膜下腔出血性脑血管痉挛的实验与临床研究[J].国外医学(脑血管疾病分册),1994,2(4):210-213. 被引量:5
  • 2Lipton RB,Diamond S,Reed M,et al.Migraine diagnosis and treatment:results from the American Migraine Study Ⅱ.Headache,2001,41:638-645.
  • 3Silberstein SD.Practice parameter:evidence-based guidelines for migraine headache (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2000,55:754-762.
  • 4Ferrari MD,Roon KI,Lipton RB,et al.Oral triptans (serotonin 5-HT(1B/1 D) agonists) in acute migraine treatment:a meta-analysis of 53 trials/ Lancet,2001,358:1668-1675.
  • 5Headache Classification Subcommittee of the International Headache Society.The Internatiional Classificatiion of Headache Disorders:2nd edition.Cephalalgia,2004,24 Suppl 1:9-160.
  • 6Lawrence EC.Diagnosis and management of migraine headaches.South Med J,2004,97:1069-1077.
  • 7Goadsby PJ,Lipton RB,Ferrari MD.Migraine-current understanding and treatment.N Engl J Med,2002,346:257-270.
  • 8Lipton RB,Stewart WF,Stone AM,et al.Stratified care vs step care strategies for migraine:the Disablility in Strategies of Care(DISC) Study:A randomized trial.JAMA,2000,284:2599-2605.
  • 9Lipton RB,Bigal ME.Migraine:epidemiology,impact,and risk factors for progression.Headache,2005,45:Suppl 1:S3-S13.
  • 10Silberstein SD,Rosenberg J.Multispecialty consensus on diagnosis and treatment of headache.Neurology,2000,54:1553.

共引文献329

同被引文献10

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部